Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...

Paweł’s decision reflects a growing challenge in Poland’s labour market. An ageing population and historically low ...

Novel combination with efti has met the trial's primary endpoint of tumour hyalinization/fibrosis in the neoadjuvant setting for patients with resectable soft tissue sarcomaDetailed results are planne ...

Na ekrany polskich kin weszła filmowa biografia polskiej noblistki - film pt. „Maria Skłodowska-Curie” w reż. Marie Noelle. Rozmawiamy z odtwórczynią tytułowej... Maria Skłodowska-Curie ...

Why Your Lifelong Fears Are Probably Groundless, Professor Wojciech Janicki, who's based at the University of Maria Curie-Sklodowska in Poland, recounted some of the things humans once feared that ...

9). Marie Curie (1867–1934) Born Maria Sklodowska, she was not allowed to go to Warsaw’s male-only university in the late 1800s, so she studied math and science on her own, working as a ...

I am therefore satisfied with these announcements," said Maria Leptin ... she wants to "strengthen" the highly appreciated Marie Sklodowska-Curie fellowships, which support young researchers.

Panteon świętych obejmuje więc tak różnorodne postacie, jak Budda, Konfucjusz, Jezus Chrystus, Muhammad, Perykles, Juliusz Cezar, Joanna d'Arc, Victor Hugo, Charlie Chaplin czy Maria Curie-Skłodowska.

Efti combination demonstrates significant tumor response in sarcoma trial, exceeding expectations without chemotherapy.

CEO Marc Voigt delivers an update on the company’s recent clinical milestones, highlighting significant progress across multiple cancer indications. The focus of the presentation is the company’s ...

chairman of the Ethics Committee of the Institute Curie and great-grandson of Maria Skłodowska-Curie. The Polish Ambassador, together with the school's management, opened an exhibition about ...

Objective To evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary antitumour activity of AMG 404, a fully human IgG1 monoclonal antibody targeting programmed cell death-1, in ...